Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.

Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.

One way to optimize the drug prescription in rheumatoid arthritis (RA) is to identify predictive biomarkers of drug responsiveness. Here, we investigated the potential "theranostic" value of proteins of the S100 family by monitoring levels of both S100A8 and S100A9 in blood samples from RA...

Full description

Bibliographic Details
Main Authors: Antoine Obry, Thierry Lequerré, Julie Hardouin, Olivier Boyer, Patrice Fardellone, Peggy Philippe, Xavier Le Loët, Pascal Cosette, Olivier Vittecoq
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4278766?pdf=render

Similar Items

Similar Items